Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-01-24
1996-11-05
Davenport, Avis M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530307, A61K 3800, A61K 3802, A61K 3830, C07K 500
Patent
active
055717888
ABSTRACT:
A stable aqueous solution of human calcitonin (hCT) which remains free of hCT fibrils for at least 24 hours at 25.degree. C. which comprises water, hCT and a cellulose derivative and/or an acid, the type of acid and the amount of acid being so chosen as to achieve said stability in the absence of a salt or a buffer.
REFERENCES:
patent: 4151276 (1979-04-01), Caulin et al.
patent: 4788221 (1988-11-01), Kagatani et al.
patent: 5002771 (1991-03-01), Purkaystha et al.
patent: 5026825 (1991-06-01), Grebow et al.
patent: 5393738 (1995-02-01), Vonderscher et al.
patent: 5440012 (1995-08-01), Takei et al.
European Search Report; EP 91 31 1176 dated Mar. 24, 1992.
Chem. Abs. 112(22) #204711y; Yamamoto et al; Calcitonin containing liquid pharmaceutical compositions for nasal applications.
Yamamoto et al., Chemical Abstracts, vol. 112, No. 22, Ab No:204711y, pp. 399, May 28, 1990.
Arvinte Tudor
Ryman Katherine D.
Ciba-Geigy Corporation
Davenport Avis M.
Fishman Irving M.
Kaiser Karen G.
Mathias Marla J.
LandOfFree
Stable calcitonin pharmaceutical compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stable calcitonin pharmaceutical compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stable calcitonin pharmaceutical compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2015221